FarmaMondo celebrates the recent successful establishment of its subsidiary in Copenhagen covering all 5 Nordic countries representing more than 27 million people. The Nordic expansion comes as a follow up to previous successful expansion to LATAM, Asia and CIS regions. FarmaMondo continues to invest in order to own localized capabilities that further allow trusted supply of unlicensed medicines to patients with unmet medical needs.
In the next years, additional expansion is planned and undergoing.
